Analystreport

Evofem Biosciences Inc (NASDAQ: EVFM) had its "buy" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $6.00 price target on the stock.

Evofem Biosciences, Inc.  (EVFM) 
Last evofem biosciences, inc. earnings: 3/12 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: evofem.com